FDA authorizes emergency use for Pfizer vaccine
The Food and Drug Administration on Friday night authorized the COVID-19 vaccine developed by Pfizer and BioNTech for emergency use, a potentially major step toward ending the coronavirus pandemic.
The still-experimental vaccine, which was found to be more than 90 percent effective in late-stage clinical trials and does not appear to cause severe side effects, is expected to be rolled out for health care workers and long-term care facility residents in the coming days, the first phase of what should be the largest vaccination campaign in U.S. history. Immediate distribution will be limited, with about 3 million doses expected in the initial shipments, but the goal is to vaccinate 20 million people by the end of the December, and another 30 million and 50 million in January and February, respectively. A second vaccine developed by Moderna, which could receive emergency use authorization as early as next week, would theoretically contribute to that total.
The U.S. joins the United Kingdom, Bahrain, and Canada in giving the shot the green light. The two-dose vaccine promises to protect against illness from COVID-19, but it's unclear if it will halt transmission. Read more at The Associated Press.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Congress starts clock on TikTok ban in foreign aid bill
Speed Read Lawmakers believe that the app poses a national security threat
By Peter Weber, The Week US Published
-
Pros and cons of universal health care
Pros and Cons A medical system that serves everyone comes with its own costs, and they're not only financial
By Rebecca Messina, The Week UK Published
-
Today's political cartoons - April 24, 2024
Cartoons Wednesday's cartoons - war on the big screen, politicians on the stock market, and more
By The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published